A randomized phase III trial of S-1/oxaliplatin (SOX) plus bevacizumab versus 5-FU/l-LV/oxaliplatin (mFOLFOX6) plus bevacizmab in patients with metastatic colorectal cancer: The SOFT study.
Daisuke Takahari
Honoraria - Chugai Pharma; Taiho Pharmaceutical; Yakult
Yasuhide Yamada
Consultant or Advisory Role - Taiho Pharmaceutical
Hiroshi Matsumoto
Honoraria - Chugai Pharma; Taiho Pharmaceutical
Hideo Baba
Consultant or Advisory Role - Taiho Pharmaceutical
Honoraria - Chugai Pharma; Pfizer; Taiho Pharmaceutical; Yakult
Research Funding - Chugai Pharma; Pfizer; Taiho Pharmaceutical; Yakult
Kazuhiro Yoshida
Consultant or Advisory Role - Chugai Pharma; Taiho Pharmaceutical
Honoraria - Chugai Pharma; Kyowa Hakko Kirin; Pfizer; Taiho Pharmaceutical; Yakult
Research Funding - Chugai Pharma; Kyowa Hakko Kirin; Pfizer; Taiho Pharmaceutical; Yakult
Masato Nakamura
Honoraria - Chugai Pharma; Pfizer; Taiho Pharmaceutical; Yakult
Motoki Yoshida
Honoraria - Chugai Pharma; Taiho Pharmaceutical
Research Funding - Chugai Pharma; Taiho Pharmaceutical; Yakult
Shigeyoshi Iwamoto
Honoraria - Chugai Pharma; Taiho Pharmaceutical; Yakult
Yasutaka Takinishi
Honoraria - Chugai Pharma; Taiho Pharmaceutical; Yakult
Research Funding - Chugai Pharma; Taiho Pharmaceutical; Yakult
Yuh Sakata
Consultant or Advisory Role - Taiho Pharmaceutical; Yakult
Honoraria - Taiho Pharmaceutical; Yakult
Satoshi Morita
Consultant or Advisory Role - Taiho Pharmaceutical
Honoraria - Chugai Pharma; Taiho Pharmaceutical; Yakult
Research Funding - Chugai Pharma; Taiho Pharmaceutical; Yakult
Yasuhiro Shimada
Consultant or Advisory Role - Taiho Pharmaceutical
Honoraria - Chugai Pharma; Taiho Pharmaceutical; Yakult
Research Funding - Chugai Pharma; Taiho Pharmaceutical
Yoshito Komatsu
Consultant or Advisory Role - Taiho Pharmaceutical
Honoraria - Chugai Pharma; Kyowa Hakko Kirin; Pfizer; Taiho Pharmaceutical; Yakult
Research Funding - Chugai Pharma; Pfizer; Taiho Pharmaceutical; Yakult
Yasutsuna Sasaki
Consultant or Advisory Role - Taiho Pharmaceutical
Honoraria - Chugai Pharma; Taiho Pharmaceutical; Yakult
Research Funding - Chugai Pharma; Taiho Pharmaceutical; Yakult
Taroh Satoh
Consultant or Advisory Role - Chugai Pharma; Taiho Pharmaceutical
Honoraria - Chugai Pharma; Kyowa Hakko Kirin; Pfizer; Taiho Pharmaceutical; Yakult
Research Funding - Chugai Pharma; Yakult
Keiichi Takahashi
Consultant or Advisory Role - Taiho Pharmaceutical
Honoraria - Chugai Pharma; Taiho Pharmaceutical; Yakult
Hideyuki Mishima
Consultant or Advisory Role - Taiho Pharmaceutical
Honoraria - Chugai Pharma; Taiho Pharmaceutical; Yakult
Research Funding - Chugai Pharma; Taiho Pharmaceutical; Yakult
Kei Muro
Consultant or Advisory Role - Taiho Pharmaceutical
Honoraria - Chugai Pharma; Kyowa Hakko Kirin; Pfizer; Taiho Pharmaceutical; Yakult
Masahiko Watanabe
Consultant or Advisory Role - Taiho Pharmaceutical
Honoraria - Chugai Pharma; Pfizer; Taiho Pharmaceutical; Yakult
Research Funding - Chugai Pharma; Pfizer; Taiho Pharmaceutical; Yakult
Kenichi Sugihara
Consultant or Advisory Role - Chugai Pharma; Merck; Taiho Pharmaceutical; Takeda; Yakult
Honoraria - Bristol-Myers Squibb; Chugai Pharma; Daiichi Sankyo; Kyowa Hakko Kirin; Merck Serono; Taiho Pharmaceutical; Takeda; Yakult
Research Funding - Bristol-Myers Squibb; Chugai Pharma; Daiichi Sankyo; Eisai; Kaken Pharmaceutical; Kyowa Hakko Kirin; Merck Serono; Otsuka; Taiho Pharmaceutical; Takeda; Wyeth; Yakult